Key facts
- Lant Medical’s last known valuation is $1.7M (Feb 2025).
- It has raised $310K; the latest was Angel (individual) ($310K) in Feb 2025.
- Notable investors include Innovate UK.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Lant Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Lant Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lant Medical
Developer of a non-antibiotic treatment intended to treat Helicobacter Pylori (H. pylori) infections. The company's treatments offer to treat the root cause and all the symptoms of H. pylori which is used as a monotherapy or in conjunction with existing therapies, enabling healthcare professionals to treat efficiently.
- Sector
- Healthcare
- HQ
- Alnwick, United Kingdom
- Founded
- 2022
- Employees
- 2
- Website
- lantmedical.com/
- Ownership
- Privately Held (backing)
Lant Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lant Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lant Medical in its N-PORT filings yet. We sweep new filings monthly.